Updated EU Guidance on Conduct of Clinical Trials During COVID-19 Pandemic

On 28 April 2020 the European Commission published an update of the guidance which it prepared with the European Medicines Agency and the national Heads of Medicines Agencies on how to manage clinical trials during the Covid-19 pandemic. 

Find the full document here: Updated EU Guidance on Conduct of Clinical Trials During COVID-19 Pandemic